Clinical trial
New Doppler Instrument for Preventing Impending Access-Graft Failure Randomized Trial
NCT00309348 is registered in ClinicalTrials.gov with DVX, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Doppler Instrument for Preventing Impending Access-Graft Failure Randomized Trial
- Lead sponsor
- DVX, LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 27, 2006
- Completion date
- April 30, 2008
- Enrollment
- 111 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hemodialysis